Pioglitazone Use and Risk of Bladder Cancer: a Systematic Review and Meta-Analysis of Observational Studies

07/11/2016
30/03/2024
EU PAS number:
EUPAS16082
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

ER-9531 TAKEDA Pioglitazone meta-analysis study protocol v1.2 20161104_clean

English (330.93 KB - PDF) View document
Study results
Study results

Pioglitazone meta-analysis report abstract 2017-04-21

English (79.87 KB - PDF) View document
Study report
Other information